Edwards Lifesciences Corporation Share Price
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.41 USD | +0.69% |
|
+6.67% | +7.46% |
| 12:05am | Edwards Lifesciences Secures US FDA Approval for Ecliptis System | MT |
| 10:53pm | Edwards Lifesciences Corporation(NYSE:EW) added to Russell Midcap Value Benchmark | CI |
| Market Cap | 5.23TCr 4.58TCr 4.23TCr 3.95TCr 7.43TCr 4,94200Cr 7.6TCr 51TCr 20TCr 2,43800Cr 20TCr 19TCr 8,46500Cr | P/E 2026 * |
32.4x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.88TCr 4.27TCr 3.94TCr 3.68TCr 6.93TCr 4,61300Cr 7.09TCr 47TCr 18TCr 2,27600Cr 18TCr 18TCr 7,90100Cr | EV / Sales 2026 * |
7.23x | EV / Sales 2027 * | 6.37x |
| Free-Float |
87.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +0.70% | ||
| 1 week | +6.67% | ||
| Current month | +5.94% | ||
| 1 month | +5.94% | ||
| 3 months | +15.23% | ||
| 6 months | +5.37% | ||
| Current year | +7.46% |
| 1 week | 85.46 |  | 92.88 |
| 1 month | 83.17 | | 92.88 |
| Current year | 74.66 | | 92.88 |
| 1 year | 72.3 | | 92.88 |
| 3 years | 58.93 | | 96.12 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/06 | Sell | Chief Executive Officer | -523 | 0.0001% | ||
| 29/05 | Sell | Controller/Auditor | -568 | 0.0001% | ||
| 27/05 | Sell | Executive/Senior Manager | -23,145 | 0.0040% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.69% | +6.67% | +17.13% | -0.45% | 5.23TCr | |
| -1.89% | +8.59% | +24.27% | -2.04% | 19TCr | |
| +0.62% | +1.00% | -25.11% | +20.23% | 14TCr | |
| -1.86% | +8.15% | -2.45% | -18.95% | 14TCr | |
| -0.69% | -1.50% | -59.35% | -18.06% | 6.57TCr | |
| -0.47% | -1.28% | -27.62% | -32.66% | 4.35TCr | |
| -2.05% | +5.33% | +12.90% | +12.86% | 3.84TCr | |
| -1.85% | +2.61% | +5.32% | +40.33% | 3.68TCr | |
| -1.41% | +6.98% | -12.42% | -17.55% | 2.99TCr | |
| -0.78% | +5.48% | -22.95% | -8.07% | 2.89TCr | |
| Average | -0.90% | +4.75% | -9.03% | -2.44% | 7.68TCr | |
| Weighted average by Cap. | -0.95% | +5.60% | -5.03% | -2.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 674.8Cr 590.86Cr 545.46Cr 509.36Cr 958.85Cr 64TCr 980.69Cr 6.56TCr 2.53TCr 31TCr 2.53TCr 2.48TCr 1,09300Cr | 741.05Cr 648.86Cr 599.01Cr 559.37Cr 1.05TCr 70TCr 1.08TCr 7.21TCr 2.78TCr 35TCr 2.78TCr 2.72TCr 1,20000Cr |
| Net income | 162.43Cr 142.22Cr 131.3Cr 122.61Cr 230.8Cr 15TCr 236.06Cr 1.58TCr 609.95Cr 7.58TCr 609.99Cr 596.6Cr 26TCr | 189.11Cr 165.59Cr 152.87Cr 142.75Cr 268.72Cr 18TCr 274.84Cr 1.84TCr 710.16Cr 8.82TCr 710.19Cr 694.61Cr 31TCr |
| Net Debt | -348.23Cr -304.91Cr -281.49Cr -262.86Cr -494.81Cr -33TCr -506.08Cr -3.39TCr -1.31TCr -16TCr -1.31TCr -1.28TCr -56TCr | -507.26Cr -444.16Cr -410.03Cr -382.9Cr -720.78Cr -48TCr -737.2Cr -4.93TCr -1.9TCr -24TCr -1.9TCr -1.86TCr -82TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | $91.43 | +0.72% | 18,42,990 |
| 26/26/26 | $90.78 | +1.18% | 1,44,20,825 |
| 25/26/25 | $89.72 | +0.07% | 43,18,766 |
| 24/26/24 | $89.66 | +3.12% | 45,11,691 |
| 23/26/23 | $86.95 | +1.25% | 42,28,237 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
